Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - enalapril maleate, quantity: 20 mg - tablet, uncoated - excipient ingredients: hypromellose; lactose monohydrate; iron oxide red; maleic acid; zinc stearate; iron oxide yellow; maize starch - hypertension. enalapril generic health is indicated in the treatment of: all grades of essential hypertension; renovascular hypertension. congestive heart failure. enalapril generic health is indicated in the treatment of all degrees of symptomatic heart failure. in such patients it is recommended that enalapril be administered together with a diuretic. left ventricular dysfunction. all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - enalapril maleate, quantity: 10 mg - tablet, uncoated - excipient ingredients: hypromellose; maleic acid; iron oxide red; zinc stearate; maize starch; lactose monohydrate - hypertension. enalapril generic health is indicated in the treatment of: all grades of essential hypertension; renovascular hypertension. congestive heart failure. enalapril generic health is indicated in the treatment of all degrees of symptomatic heart failure. in such patients it is recommended that enalapril be administered together with a diuretic. left ventricular dysfunction. all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - enalapril maleate, quantity: 5 mg - tablet, uncoated - excipient ingredients: maleic acid; zinc stearate; maize starch; hypromellose; lactose monohydrate - hypertension. enalapril generic health is indicated in the treatment of: all grades of essential hypertension; renovascular hypertension. congestive heart failure. enalapril generic health is indicated in the treatment of all degrees of symptomatic heart failure. in such patients it is recommended that enalapril be administered together with a diuretic. left ventricular dysfunction. all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - lisinopril dihydrate, quantity: 21.78 mg (equivalent: lisinopril, qty 20 mg) - tablet, uncoated - excipient ingredients: maize starch; pregelatinised maize starch; iron oxide red; colloidal anhydrous silica; mannitol; magnesium stearate; calcium hydrogen phosphate dihydrate - hypertension. lisinopril generic health tablets are indicated in the treatment of hypertension. it may be used alone or concomitantly with other classes of antihypertensive agents. sufficient data have not been provided to support the use of lisinopril in severe hypertension or renovascular hypertension. congestive heart failure lisinopril generic health tablets are also indicated in the treatment of heart failure. in such patients, it is recommended that lisinopril generic health tablets be administered together with a diuretic. acute myocardial infarction: lisinopril generic health tablets are indicated for the treatment of acute myocardial infarction in haemodynamically stable patients, defined as patients who are not in cardiogenic shock and who have a systolic blood pressure greater than 100mmhg. lisinopril may be initiated within 24 hours of an acute myocardial infarction.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - lisinopril dihydrate, quantity: 10.89 mg (equivalent: lisinopril, qty 10 mg) - tablet, uncoated - excipient ingredients: magnesium stearate; iron oxide red; colloidal anhydrous silica; mannitol; maize starch; calcium hydrogen phosphate dihydrate; pregelatinised maize starch - hypertension. lisinopril generic health tablets are indicated in the treatment of hypertension. it may be used alone or concomitantly with other classes of antihypertensive agents. sufficient data have not been provided to support the use of lisinopril in severe hypertension or renovascular hypertension. congestive heart failure lisinopril generic health tablets are also indicated in the treatment of heart failure. in such patients, it is recommended that lisinopril generic health tablets be administered together with a diuretic. acute myocardial infarction: lisinopril generic health tablets are indicated for the treatment of acute myocardial infarction in haemodynamically stable patients, defined as patients who are not in cardiogenic shock and who have a systolic blood pressure greater than 100mmhg. lisinopril may be initiated within 24 hours of an acute myocardial infarction.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - lisinopril dihydrate, quantity: 5.44 mg (equivalent: lisinopril, qty 5 mg) - tablet, uncoated - excipient ingredients: iron oxide red; calcium hydrogen phosphate dihydrate; mannitol; pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate; maize starch - hypertension. lisinopril generic health tablets are indicated in the treatment of hypertension. it may be used alone or concomitantly with other classes of antihypertensive agents. sufficient data have not been provided to support the use of lisinopril in severe hypertension or renovascular hypertension. congestive heart failure lisinopril generic health tablets are also indicated in the treatment of heart failure. in such patients, it is recommended that lisinopril generic health tablets be administered together with a diuretic. acute myocardial infarction: lisinopril generic health tablets are indicated for the treatment of acute myocardial infarction in haemodynamically stable patients, defined as patients who are not in cardiogenic shock and who have a systolic blood pressure greater than 100mmhg. lisinopril may be initiated within 24 hours of an acute myocardial infarction.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: colloidal anhydrous silica; macrogol 6000; maize starch; purified talc; crospovidone; magnesium stearate; microcrystalline cellulose; sunset yellow fcf aluminium lake; lactose monohydrate; hypromellose; titanium dioxide; indigo carmine aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - amitriptyline hydrochloride, quantity: 10 mg - tablet - excipient ingredients: maize starch; titanium dioxide; lactose monohydrate; macrogol 6000; hypromellose; purified talc; crospovidone; colloidal anhydrous silica; brilliant blue fcf aluminium lake; magnesium stearate; microcrystalline cellulose - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - amitriptyline hydrochloride, quantity: 25 mg - tablet - excipient ingredients: titanium dioxide; purified talc; hypromellose; microcrystalline cellulose; macrogol 6000; quinoline yellow aluminium lake; lactose monohydrate; crospovidone; colloidal anhydrous silica; magnesium stearate; maize starch - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - cefalexin, quantity: 500 mg - capsule - excipient ingredients: gelatin; titanium dioxide; patent blue v; sodium lauryl sulfate; magnesium stearate; microcrystalline cellulose; sunset yellow fcf; quinoline yellow; purified water; propylene glycol; butan-1-ol; isopropyl alcohol; ethanol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; ethanol absolute - respiratory tract infections caused by s. pneumoniae and group a beta-haemolytic streptococci (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cephalexin generichealth capsules are generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin capsules in the subsequent prevention of rheumatic fever are not available at present). bacterial sinusitis caused by streptococci, s. pneumoniae and s. aureus (methicillin sensitive only). otitis media. due to s. pneumoniae, staphylococci. skin and soft tissue infections caused by staphylococci and/or streptococci. genitourinary tract infections, including acute prostatitis caused by e. coli, p. mirabilis and klebsiella sp. the effectiveness of cephalexin generichealth capsules in the treatment of bacterial infections of the brain and spinal column has not been established and cephalexin generi